{"groups":[{"description":"Induction: Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab\n\nCarfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab: Experimental","id":"FG000","title":"KRd-Daratumumab"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"24"}],"type":"Still On Study (on study treatment)"},{"reasons":[{"groupId":"FG000","numSubjects":"12"}],"type":"Still On Study (in follow up)"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"39"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"39"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}